Medical Device Vendor Qualification Checklist

A risk based checklist for legal identity, quality systems, product scope, traceability, logistics, complaints and financial controls. The purpose is to help teams make a clearer, better documented decision without turning a commercial checklist into a clinical recommendation.

Quick answer

Vendor onboarding can become a paperwork exercise that does not test whether the supplier can accurately fulfil a real medical device order. A stronger approach produces qualification evidence tied to an approved scope and ongoing performance review.

This cluster article supports the broader guide on Medical Device Tender Preparation: A Step by Step Guide. The main search topic for this guide is medical device vendor qualification. Related language includes medical supplier audit checklist, healthcare vendor onboarding, medical device supplier evaluation, but the article uses those terms only where they help the reader rather than repeating them mechanically.

Why this matters

A medical device tender should convert a clinical and operational need into clear, testable requirements. The evaluation model must be written before bids are reviewed, and mandatory failures should not be hidden inside a high total score.

For procurement, quality, finance and healthcare vendor management teams, the practical risk is not limited to price. A wrong reference, incomplete pack, uncertain shelf life, late shipment or unsupported alternative can create rework, unused inventory and avoidable delays. A useful buying process therefore connects the technical request, commercial offer and receiving standard.

The best time to resolve ambiguity is before the purchase order. Once goods are dispatched, every unclear field becomes harder and more expensive to correct. The controls below are designed to move important questions to the beginning of the process.

Key checks

These checks should be adapted to product risk and organisational policy. A routine low risk item and a sterile implantable or procedure critical device should not automatically receive the same depth of review.

A practical workflow

1. Step 1: Classify vendor risk and required evidence. Record the owner, evidence and completion date so the action can be checked later.
2. Step 2: Collect a standard prequalification submission. Record the owner, evidence and completion date so the action can be checked later.
3. Step 3: Verify critical information independently. Record the owner, evidence and completion date so the action can be checked later.
4. Step 4: Run a sample RFQ or trial order where suitable. Record the owner, evidence and completion date so the action can be checked later.
5. Step 5: Approve the vendor for a defined scope and period. Record the owner, evidence and completion date so the action can be checked later.
6. Step 6: Monitor performance and renew or restrict approval. Record the owner, evidence and completion date so the action can be checked later.

A workflow is only useful when exceptions are visible. If a field is unknown, mark it as unknown and assign an owner. Do not fill the gap with an assumption merely to complete the form. The decision record should show what was confirmed, what remained conditional and which stakeholder accepted the residual risk.

Documentation and verification

Vendor evidence should match the approved scope. Legal documents, quality controls, product capability, logistics, service and commercial integrity all matter, but the depth of review should remain proportionate to product and supply risk.

The tender and vendor file should allow another reviewer to follow the decision without relying on memory. Clarifications, scoring, conflicts, approvals, mobilisation actions and performance reviews should be documented consistently.

For every important document, record the document title, issuing organisation, product or company scope, version or validity date, source and date reviewed. This simple index helps prevent a valid document from being attached to the wrong product or reused after it becomes outdated.

Minimum decision record

• The original request and clinician or technical approval where required
• The exact quoted product identity, pack and quantity
• Supplier assumptions, deviations and proposed alternatives
• Quality, regulatory and traceability evidence proportionate to risk
• Price basis, landed cost assumptions, lead time and shelf life
• Approval names, dates and any conditions
• Receiving checks and final disposition of discrepancies

Questions to ask before approval

• Can the supplier demonstrate the corporate identity described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the product capability described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the quality controls described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the delivery capability described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the commercial integrity described in the RFQ, and can the answer be connected to the exact quoted product?

Ask suppliers to answer against each RFQ line rather than in a general email. A line level response makes it easier to compare offers, detect partial matches and transfer the approved information into the purchase order.

Common mistakes

• Approving a vendor for every product after one successful order. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
• Accepting expired licences or certificates. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
• Skipping bank detail verification. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
• Failing to suspend approval after serious unresolved issues. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.

Most procurement errors are not caused by one dramatic failure. They develop through several small gaps, such as an abbreviated name, an unrecorded assumption and a receiving check that compares quantity but not reference. Closing those gaps consistently is more effective than adding a large document request after a problem occurs.

Practical example

The lesson is not that every enquiry must become slow. A structured template is usually faster because it reduces repeated emails and makes approval requirements visible from the start.

Final checklist

• ✓ Corporate identity has been reviewed: Verify legal name, licence, ownership, address, banking and authorised contacts.
• ✓ Product capability has been reviewed: Define the brands, product categories and services being approved.
• ✓ Quality controls has been reviewed: Review document control, source verification, storage, traceability, complaints and recalls.
• ✓ Delivery capability has been reviewed: Assess inventory, lead time control, logistics partners and escalation.
• ✓ Commercial integrity has been reviewed: Review quotation accuracy, tax, payment, insurance and conflict declarations as applicable.

Before closing the file, confirm that the purchase order reflects the approved quotation rather than an earlier draft. At receiving, compare the physical label and condition with the same approved record. This completes the link between request, order and delivered product.

Frequently asked questions

Related AJA guides

• Medical Device Tender Preparation: A Step by Step GuideA structured tender workflow covering need definition, specifications, bidder evidence, evaluation, award and contract mobilisation.
• Total Cost of Ownership in Medical Device ProcurementA practical model for comparing purchase price with freight, consumables, training, maintenance, downtime, waste and end of life costs.
• Emergency Medical Device Sourcing During ShortagesA rapid but controlled sourcing process for urgent shortages, including reference verification, escalation and temporary approvals.

Browse the medical device product catalogue, review the brand sourcing profiles or read about AJA International’s quality and compliance approach.

Official resources and further reading

• WHO health product procurement resources
• European Commission medical devices sector
• FDA medical device information

Editorial review: Prepared for publication in 2026. Regulatory, registration and product information can change, so readers should confirm current requirements and manufacturer documentation before acting.